PT - JOURNAL ARTICLE AU - Haunhorst, Simon AU - Bloch, Wilhelm AU - Javelle, Florian AU - Krüger, Karsten AU - Baumgart, Sabine AU - Drube, Sebastian AU - Lemhöfer, Christina AU - Reuken, Philipp AU - Stallmach, Andreas AU - Müller, Michael AU - Zielinski, Christina E. AU - Pletz, Mathias W. AU - Gabriel, Holger H.W. AU - Puta, Christian TI - A scoping review of regulatory T cell dynamics in convalescent COVID-19 patients – Implications for Long COVID? AID - 10.1101/2022.10.04.22280642 DP - 2022 Jan 01 TA - medRxiv PG - 2022.10.04.22280642 4099 - http://medrxiv.org/content/early/2022/10/04/2022.10.04.22280642.short 4100 - http://medrxiv.org/content/early/2022/10/04/2022.10.04.22280642.full AB - Background Recovery from coronavirus disease 2019 (COVID-19) can be impaired by the persistence of symptoms or new-onset health complications, commonly referred to as Long COVID. In a subset of patients, Long COVID is associated with immune system perturbations of unknown etiology, which could be related to compromised immunoregulatory mechanisms.Objective The aim of this scoping review was to investigate if regulatory T cell (Treg) dysregulation is observable beyond the acute illness and if it might be involved in Long COVID immunopathology.Design A systematic search of studies investigating Tregs during COVID-19 convalescence was conducted on MEDLINE (via Pubmed) and Web of Science.Results The literature search yielded 17 relevant studies, of which three included a distinct cohort of patients with Long COVID. The reviewed studies suggest that the Treg population of COVID-19 patients can reconstitute quantitatively and functionally during recovery. However, the comparison between recovered and seronegative controls revealed that an infection-induced dysregulation of the Treg compartment can be sustained for at least several months. The small number of studies investigating Tregs in Long COVID allowed no firm conclusions to be drawn about their involvement in the syndrome’s etiology. Yet, even almost one year post-infection Long COVID patients exhibit significantly altered proportions of Tregs within the CD4+ T cell population.Conclusions Persistent alterations in cell frequency in Long COVID patients indicate that Treg dysregulation might be linked to immune system-associated sequelae. Future studies should aim to address the association of Treg adaptations with different symptom clusters and blood parameters beyond the sole quantification of cell frequencies while adhering to consensualized phenotyping strategies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by BMBF Verbundprojekt SARS-CoV-2Dx, Leibniz Center for Photonics in Infection Research (LPI-BT6, CEZ), Germany's Excellence Strategy (Balance of the Microverse, C.E.Z) Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript.